Cargando…

Innovative strategies for the elimination of viral hepatitis at a national level: A country case series

Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost‐effective. In 2016, all 194 member states...

Descripción completa

Detalles Bibliográficos
Autores principales: Schröeder, Sophia E., Pedrana, Alisa, Scott, Nick, Wilson, David, Kuschel, Christian, Aufegger, Lisa, Atun, Rifat, Baptista‐Leite, Ricardo, Butsashvili, Maia, El‐Sayed, Manal, Getahun, Aneley, Hamid, Saeed, Hammad, Radi, ‘t Hoen, Ellen, Hutchinson, Sharon J., Lazarus, Jeffrey V., Lesi, Olufunmilayo, Li, Wangsheng, Binti Mohamed, Rosmawati, Olafsson, Sigurdur, Peck, Raquel, Sohn, Annette H., Sonderup, Mark, Spearman, Catherine W., Swan, Tracy, Thursz, Mark, Walker, Tim, Hellard, Margaret, Howell, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790606/
https://www.ncbi.nlm.nih.gov/pubmed/31433902
http://dx.doi.org/10.1111/liv.14222
_version_ 1783458808017715200
author Schröeder, Sophia E.
Pedrana, Alisa
Scott, Nick
Wilson, David
Kuschel, Christian
Aufegger, Lisa
Atun, Rifat
Baptista‐Leite, Ricardo
Butsashvili, Maia
El‐Sayed, Manal
Getahun, Aneley
Hamid, Saeed
Hammad, Radi
‘t Hoen, Ellen
Hutchinson, Sharon J.
Lazarus, Jeffrey V.
Lesi, Olufunmilayo
Li, Wangsheng
Binti Mohamed, Rosmawati
Olafsson, Sigurdur
Peck, Raquel
Sohn, Annette H.
Sonderup, Mark
Spearman, Catherine W.
Swan, Tracy
Thursz, Mark
Walker, Tim
Hellard, Margaret
Howell, Jessica
author_facet Schröeder, Sophia E.
Pedrana, Alisa
Scott, Nick
Wilson, David
Kuschel, Christian
Aufegger, Lisa
Atun, Rifat
Baptista‐Leite, Ricardo
Butsashvili, Maia
El‐Sayed, Manal
Getahun, Aneley
Hamid, Saeed
Hammad, Radi
‘t Hoen, Ellen
Hutchinson, Sharon J.
Lazarus, Jeffrey V.
Lesi, Olufunmilayo
Li, Wangsheng
Binti Mohamed, Rosmawati
Olafsson, Sigurdur
Peck, Raquel
Sohn, Annette H.
Sonderup, Mark
Spearman, Catherine W.
Swan, Tracy
Thursz, Mark
Walker, Tim
Hellard, Margaret
Howell, Jessica
author_sort Schröeder, Sophia E.
collection PubMed
description Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost‐effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis responses across a range of settings, with different levels of available resources and infrastructural development. These case studies demonstrate the utility of taking a multipronged, public health approach to: (a) evidence‐gathering and planning; (b) implementation; and (c) integration of viral hepatitis services into the Agenda for Sustainable Development. They provide models for planning, investment and implementation strategies for other countries facing similar challenges and resource constraints.
format Online
Article
Text
id pubmed-6790606
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67906062019-10-18 Innovative strategies for the elimination of viral hepatitis at a national level: A country case series Schröeder, Sophia E. Pedrana, Alisa Scott, Nick Wilson, David Kuschel, Christian Aufegger, Lisa Atun, Rifat Baptista‐Leite, Ricardo Butsashvili, Maia El‐Sayed, Manal Getahun, Aneley Hamid, Saeed Hammad, Radi ‘t Hoen, Ellen Hutchinson, Sharon J. Lazarus, Jeffrey V. Lesi, Olufunmilayo Li, Wangsheng Binti Mohamed, Rosmawati Olafsson, Sigurdur Peck, Raquel Sohn, Annette H. Sonderup, Mark Spearman, Catherine W. Swan, Tracy Thursz, Mark Walker, Tim Hellard, Margaret Howell, Jessica Liver Int Reviews Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost‐effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis responses across a range of settings, with different levels of available resources and infrastructural development. These case studies demonstrate the utility of taking a multipronged, public health approach to: (a) evidence‐gathering and planning; (b) implementation; and (c) integration of viral hepatitis services into the Agenda for Sustainable Development. They provide models for planning, investment and implementation strategies for other countries facing similar challenges and resource constraints. John Wiley and Sons Inc. 2019-09-04 2019-10 /pmc/articles/PMC6790606/ /pubmed/31433902 http://dx.doi.org/10.1111/liv.14222 Text en © 2019 The Authors. Liver International published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Schröeder, Sophia E.
Pedrana, Alisa
Scott, Nick
Wilson, David
Kuschel, Christian
Aufegger, Lisa
Atun, Rifat
Baptista‐Leite, Ricardo
Butsashvili, Maia
El‐Sayed, Manal
Getahun, Aneley
Hamid, Saeed
Hammad, Radi
‘t Hoen, Ellen
Hutchinson, Sharon J.
Lazarus, Jeffrey V.
Lesi, Olufunmilayo
Li, Wangsheng
Binti Mohamed, Rosmawati
Olafsson, Sigurdur
Peck, Raquel
Sohn, Annette H.
Sonderup, Mark
Spearman, Catherine W.
Swan, Tracy
Thursz, Mark
Walker, Tim
Hellard, Margaret
Howell, Jessica
Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
title Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
title_full Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
title_fullStr Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
title_full_unstemmed Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
title_short Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
title_sort innovative strategies for the elimination of viral hepatitis at a national level: a country case series
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790606/
https://www.ncbi.nlm.nih.gov/pubmed/31433902
http://dx.doi.org/10.1111/liv.14222
work_keys_str_mv AT schroedersophiae innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT pedranaalisa innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT scottnick innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT wilsondavid innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT kuschelchristian innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT aufeggerlisa innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT atunrifat innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT baptistaleitericardo innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT butsashvilimaia innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT elsayedmanal innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT getahunaneley innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT hamidsaeed innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT hammadradi innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT thoenellen innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT hutchinsonsharonj innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT lazarusjeffreyv innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT lesiolufunmilayo innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT liwangsheng innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT bintimohamedrosmawati innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT olafssonsigurdur innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT peckraquel innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT sohnannetteh innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT sonderupmark innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT spearmancatherinew innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT swantracy innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT thurszmark innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT walkertim innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT hellardmargaret innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries
AT howelljessica innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries